The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has begun an early-stage clinical trial of an investigational vaccine designed to protect against yellow fever virus.

Read this article:
NIAID begins early-stage trial of experimental vaccine for preventing yellow fever virus

Scroll to Top